Nadine M. Shaban

Nadine M. Shaban

Auto-generated profile, based on publicly available information

Nadine M. Shaban

University of Minnesota

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ACAdam Z. Cheng
Adam Z. Cheng
SMSofia Moraes
Sofia Moraes
NSNadine M. Shaban
Nadine M. Shaban
Elisa FanunzaElisa Fanunza
Elisa Fanunza
CBCraig Bierle
Craig Bierle
RHReuben Harris
Reuben Harris
The apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) family of DNA cytosine deaminases provides a broad and overlapping defense against viral infections. Successful viral pathogens, by definition, have evolved strategies to escape restriction by the APOBEC enzymes of their hosts. HIV-1 and related retroviruses are thought to be the predominant natural substrates of APOBEC enzymes due to obligate single-stranded (ss)DNA replication intermediates, abundant evidence for cDNA strand C-to-U editing (genomic strand G-to-A hypermutation), and a potent APOBEC degradation mechanism. In contrast, much lower mutation rates are observed in double-stranded DNA herpesviruses and the evidence for APOBEC mutation has been less compelling. However, recent work has revealed that Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), and herpes simplex virus-1 (HSV-1) are potential substrates for cellular APOBEC enzymes. To prevent APOBEC-mediated restriction these viruses have repurposed their ribonucleotide reductase (RNR) large subunits to directly bind, inhibit, and relocalize at least two distinct APOBEC enzymes—APOBEC3B and APOBEC3A. The importance of this interaction is evidenced by genetic inactivation of the EBV RNR (BORF2), which results in lower viral infectivity and higher levels of C/G-to-T/A hypermutation. This RNR-mediated mechanism therefore likely functions to protect lytic phase viral DNA replication intermediates from APOBEC-catalyzed DNA C-to-U deamination. The RNR-APOBEC interaction defines a new pathogen-host conflict that the virus must win in real-time for transmission and pathogenesis. However, partial losses over evolutionary time may also benefit the virus by providing mutational fuel for adaptation.

1 June 2016 in Journal of Molecular Biology
Verified
Journal Article
Closed access
NSNadine M. Shaban
Nadine M. Shaban
KSKe Shi
Ke Shi
MLMing Li
Ming Li
HAHideki Aihara
Hideki Aihara
RHReuben Harris
Reuben Harris

29 April 2022 in Science Advances
Verified
Journal Article
Open access
NSNadine M. Shaban
Nadine M. Shaban
RYRui Yan
Rui Yan
KSKe Shi
Ke Shi
SMSofia Moraes
Sofia Moraes
ACAdam Z. Cheng
Adam Z. Cheng
RHReuben Harris
Reuben Harris
Viruses use a plethora of mechanisms to evade immune responses. A recent example is neutralization of the nuclear DNA cytosine deaminase APOBEC3B by the Epstein-Barr virus (EBV) ribonucleotide reductase subunit BORF2. Cryo-EM studies of APOBEC3B-BORF2 complexes reveal a large >1000-Å 2 binding surface composed of multiple structural elements from each protein, which effectively blocks the APOBEC3B active site from accessing single-stranded DNA substrates. Evolutionary optimization is suggested by unique insertions in BORF2 absent from other ribonucleotide reductases and preferential binding to APOBEC3B relative to the highly related APOBEC3A and APOBEC3G enzymes. A molecular understanding of this pathogen-host interaction has potential to inform the development of drugs that block the interaction and liberate the natural antiviral activity of APOBEC3B. In addition, given a role for APOBEC3B in cancer mutagenesis, it may also be possible for information from the interaction to be used to develop DNA deaminase inhibitors.

1 December 2019 in Journal of Molecular Biology
Verified
Journal Article
Closed access
JWJiayi Wang
Jiayi Wang
JBJordan T. Becker
Jordan T. Becker
KSKe Shi
Ke Shi
KLKate V. Lauer
Kate V. Lauer
DSDaniel J. Salamango
Daniel J. Salamango
RHReuben Harris
Reuben Harris

31 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNadine M. Shaban
Nadine M. Shaban
RYRui Yan
Rui Yan
KSKe Shi
Ke Shi
SMSofia N. Moraes
Sofia N. Moraes
ACAdam Z. Cheng
Adam Z. Cheng
RHReuben Harris
Reuben Harris
Viruses use a plethora of mechanisms to evade immune responses. A new example is neutralization of the nuclear DNA cytosine deaminase APOBEC3B by the Epstein-Barr virus (EBV) ribonucleotide reductase subunit BORF2. Cryo-EM studies of APOBEC3B-BORF2 complexes reveal a large >1000 Å 2 binding surface comprised of multiple structural elements from each protein, which effectively blocks the APOBEC3B active site from accessing single-stranded DNA substrates. Evolutionary optimization is suggested by unique insertions in BORF2 absent from other ribonucleotide reductases and preferential binding to APOBEC3B relative to the highly related APOBEC3A and APOBEC3G enzymes. An atomic understanding of this novel pathogen-host interaction may contribute to the development of drugs that block the interaction and liberate the natural antiviral activity of APOBEC3B. One-Sentence Summary: These studies show how a conserved viral nucleotide metabolism protein is repurposed to inhibit a potent antiviral factor.

13 October 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNadine M. Shaban
Nadine M. Shaban
KSKe Shi
Ke Shi
KLKate V. Lauer
Kate V. Lauer
MCMichael A. Carpenter
Michael A. Carpenter
CRChristopher M. Richards
Christopher M. Richards
RHReuben Harris
Reuben Harris
SUMMARY: Human APOBEC3H and homologous single-stranded DNA cytosine deaminases are unique to mammals. These DNA editing enzymes function in innate immunity by restricting the replication of viruses and transposons. Misregulated APOBEC3H also contributes to cancer mutagenesis. Here we address the role of RNA in APOBEC3H regulation. APOBEC3H co-purifies with RNA as an inactive protein, and RNase A treatment yields enzyme preparations with stronger DNA deaminase activity. RNA binding-defective mutants are DNA hypermutators. Chromatography profiles and crystallographic data demonstrate a mechanism in which double-stranded RNA mediates enzyme dimerization. RNA binding is required for APOBEC3H cytoplasmic localization and for packaging into HIV-1 particles and antiviral activity. Related DNA deaminases including other APOBEC3 family members and the antibody gene diversification enzyme AID also bind RNA and are predicted to have a similar RNA binding motif suggesting mechanistic conservation and relevance to innate and adaptive immunity and to multiple diseases. HIGHLIGHTS: RNA inhibits human APOBEC3H DNA cytosine deaminase activity RNA binding mutants are DNA hypermutators X-ray structure demonstrates an RNA duplex-mediated APOBEC3H dimerization mechanism RNA binding is required for packaging into HIV-1 particles and antiviral activity